Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 8 Medulloblastoma 5 Recurrence 4 Thrombocythemia, Essential 2 Skin Neoplasms 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Ovarian Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Astrocytoma 2 Thrombocytosis 1 Stomach Neoplasms 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms, Basal Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1

Interventions

Fulvestrant 5 Anastrozole 4 Letrozole 3 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 exemestane 1 cediranib 1 XMT-1522 1 Vorinostat 1 Tablets 1 Ritonavir 1 Population Groups 1 Paclitaxel 1 Moxifloxacin 1 Itraconazole 1 Histone Deacetylase Inhibitors 1 Gemcitabine 1 FCN-437c 1 Everolimus 1 Electroporation 1 Cryosurgery 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Breast Cancer × sonidegib × Clear all

NCT02027376 2023-04-03

EDALINE

Spanish Breast Cancer Research Group

Phase 1 Completed

12 enrolled 16 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡